Please login to the form below

Not currently logged in
Email:
Password:

Astellas 'Changing Tomorrow' award winners

Astellas Pharma Europe launched its 'Changing Tomorrow' charity awards, and announced the first winners

Astellas Pharma Europe launched its 'Changing Tomorrow' charity awards, and announced the first winners.

The awards are designed to reward organisations working across all communities to help individuals realise their full potential and enhance their quality of life both now and in the future.

The first four recipients of the award, selected for the life-changing contributions they have made, are:
· CliniClowns – a Dutch organisation which arranges for clowns to visit sick children in hospital
· The International Foundation for Dermatology (IFD) – a non-profit organisation working to improve dermatologic care in rural areas of developing countries
· The Prostate Cancer Charity – the UK's leading voluntary organisation working with people affected by prostate cancer; and
· Save the Children – the Cyclone Nargis, Burma Fund.

Masao Yoshida, president and CEO of Astellas Pharma Europe, said: "Astellas takes its responsibility to society seriously and is committed to changing the lives of people around the world. We support worthwhile causes that make a difference; the four charities chosen to receive the Astellas 'Changing Tomorrow' charity awards are all striving to create a brighter future in their respective fields."

The 'Changing Tomorrow' awards are the latest initiative in Astellas' ethical commitment to support medical research and education on a global level. The company also runs a series of Corporate Social responsibility (CSR) programmes, which includes a registered charity supporting programmes and activities that will lead to a healthy society – the Astellas European Foundation.

Commenting on the award, John Neate, CEO of The Prostate Cancer Charity, said: "The Prostate Cancer Charity is delighted to have received this award and the associated funding. This contribution will help us to continue to raise awareness of prostate cancer and finance research, in addition to providing practical support and information to men affected by prostate cancer, the most common cancer in men in the UK, and their families."

24th September 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics